Screening for prostate cancer becomes more complex in men over the age of 70. The US Preventive Services Task Force (USPSTF) currently recommends against routine PSA testing in this age group. The PSA ...

A new review in Medical Oncology details how liquid biomarkers, advanced imaging, and artificial intelligence are transforming pre-biopsy discrimination of prostate cancer from benign disease.

For a man facing a prostate biopsy, an MRI scan can give doctors a clearer idea of where to look for cancer before they ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

Prostate cancer is often dramatically different from one man to another. For some patients, the disease grows slowly and can ...

Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the Garvan Institute of Medical Research have produced the world's most ...

A 58-year-old businessman walks into a clinic for a routine health check. He feels fine. No pain, no urinary trouble, nothing ...

In a biopsy, a small sample of tissue is taken from your body. A pathologist analyzes the sample to check for cancer cells. The main method for diagnosing prostate cancer is a core needle biopsy. It’s ...

About one in eight American men will be diagnosed with prostate cancer during their lifetime. It is the second-deadliest cancer for American men, claiming tens of thousands of lives every year. Today, ...

Can dogs combined with machine learning help detect human prostate cancer? Artificial intelligence (AI) is increasingly being applied as a tool to assist in creating novel diagnostics and treatments ...